tb-500 mastery course
Unit 1 of 12 -- free

TB-500: the thymosin beta-4 fragment

how a fragment of a thymus hormone became one of the most discussed repair peptides in research and athletics

The Thymosin Beta-4 Fragment

In 1966, Allan Goldstein and his team at the Albert Einstein College of Medicine began isolating a family of small proteins from the thymus gland. They called them thymosins -- and over the following decades, this family would grow to include dozens of members with roles far beyond immune function. One of those members, thymosin beta-4 (Tb4), turned out to be the most abundant intracellular peptide in nearly every nucleated cell in the human body.

TB-500 is a synthetic version of the active region of Tb4 -- a 43-amino-acid peptide that preserves the critical LKKTET sequence responsible for Tb4's actin-binding and tissue repair properties. where full-length Tb4 is difficult and expensive to synthesize at scale, TB-500 captures the functional core in a commercially viable form. it has been studied in animal models for wound healing, cardiac repair, anti-inflammatory activity, and cell migration -- and banned by WADA since 2010 under the category of peptide hormones and growth factors.


Thymosin Family Origins

From thymus extract to a family of 43 beta-thymosins found in nearly every cell in the body.

Goldstein's original thymosin fraction 5 was a crude extract from calf thymus tissue. throughout the 1970s and 1980s, researchers separated this fraction into individual peptides and classified them by isoelectric point into three families: alpha, beta, and gamma thymosins.

the beta-thymosins turned out to be far more than immune modulators. thymosin beta-4 (Tb4), a 43-amino-acid peptide with the sequence beginning Ac-SDKP..., was found at high concentrations in platelets, wound fluid, and virtually all nucleated cells. its primary intracellular role is sequestering G-actin monomers -- preventing them from polymerizing into filaments until the cell signals for cytoskeletal reorganization.

TB-500 replicates the 17-amino-acid active region of Tb4 centered on the LKKTET motif (residues 17-23), which is the actin-binding domain responsible for the peptide's effects on cell migration, angiogenesis, and tissue repair. the synthetic fragment retains the biological activity of full-length Tb4 while being simpler and cheaper to produce.

43
amino acids (Tb4)
1966
Goldstein thymosin discovery
~4,921
daltons molecular weight
LKKTET
active motif sequence

The LKKTET Motif

Six amino acids that drive actin binding, cell migration, and wound repair.

interactive discovery timeline

the LKKTET sequence (Leu-Lys-Lys-Thr-Glu-Thr) at positions 17-22 of Tb4 is the minimum fragment required for G-actin sequestration. when this motif binds monomeric actin, it prevents spontaneous polymerization -- giving the cell precise control over when and where actin filaments form.

this matters because actin dynamics drive cell movement. when a cell migrates toward a wound site, it needs to rapidly polymerize actin at its leading edge while depolymerizing at the trailing edge. Tb4 (and by extension TB-500) provides the reservoir of sequestered G-actin that feeds this process.

beyond actin binding, the LKKTET region has been shown to promote angiogenesis (new blood vessel formation), reduce inflammation through NF-kB pathway modulation, and activate satellite cells in muscle tissue -- all in animal models.


Tissue Repair Mechanisms

An overview of the four primary pathways through which TB-500 is proposed to promote healing.

actin regulation: by sequestering G-actin monomers, TB-500 maintains a pool of building blocks that cells can rapidly deploy for migration and cytoskeletal reorganization during tissue repair.

cell migration: TB-500 upregulates the ILK/PINCH/parvin complex, which activates Akt signaling and promotes directional cell movement toward injury sites. this has been demonstrated in keratinocyte, endothelial, and corneal epithelial cell models.

angiogenesis: animal studies show TB-500 promotes new blood vessel formation through VEGF upregulation and endothelial cell tube formation, providing the vascular supply needed for tissue regeneration.

anti-inflammatory activity: TB-500 suppresses NF-kB nuclear translocation, reduces pro-inflammatory cytokines (TNF-alpha, IL-1beta, IL-6), and decreases MMP activity -- reducing the destructive phase of inflammation so repair can proceed.

4
primary repair pathways
0
FDA-approved uses
2010
WADA ban year
Tier 3
evidence level
important context: this course covers TB-500 for educational purposes only. TB-500 is not FDA-approved for any human use. it is banned by WADA in competitive sports. all data discussed is from animal studies or in vitro experiments unless explicitly stated otherwise. consult a healthcare professional for any medical decisions.

The WADA Ban

Why TB-500 was added to the World Anti-Doping Agency prohibited list in 2010.

in 2010, WADA added thymosin beta-4 and its fragments (including TB-500) to the prohibited list under section S2: peptide hormones, growth factors, and related substances. the ban was driven by the peptide's demonstrated ability to promote tissue repair and angiogenesis in animal models -- properties that could provide an unfair advantage in recovery from training and injury.

the ban came after TB-500 had already gained popularity in equine racing, where it was marketed under trade names like Tβ4 Equine for racehorse recovery. several high-profile doping cases in Australian horse racing between 2008-2012 brought TB-500 into public awareness and accelerated regulatory scrutiny.

despite the ban, TB-500 remains widely available through research chemical suppliers and online peptide vendors. its legal status varies by country -- it is not a controlled substance in most jurisdictions, but its sale for human consumption is prohibited in the United States.


What's Ahead

This is unit 1 of a 12-unit mastery course covering everything known about TB-500.

in the units ahead, you'll learn the molecular structure of TB-500 and its relationship to full-length Tb4, how actin biology underpins its mechanism of action, the cell migration and angiogenesis pathways it activates, its anti-inflammatory mechanisms, detailed research on wound healing, cardiac repair, and neuroprotection, the state of clinical trials, dosing protocols and safety data, and the regulatory landscape across jurisdictions.

every claim is traced back to its primary research source, and every limitation is clearly stated. this course is designed to give you the knowledge to evaluate TB-500 claims critically -- not to promote its use.

what's ahead: units 2-11 cover molecular structure, actin biology, cell migration and angiogenesis, anti-inflammatory mechanisms, wound healing, cardiac and neurological research, clinical trials, dosing and administration, safety, and the regulatory landscape. unit 12 is a comprehensive final exam with specialist certification.

Knowledge Check

Test what you've learned about TB-500's origins and research landscape.


Practice Exercises

Reinforce your understanding with interactive exercises.

Next Unit

Molecular Structure